2024 HCPCS Code C9093

Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

Notice	HCPCS C9093 terminated on June 30, 2022.
Short Description	Inj., susvimo, 0.1 mg
HCPCS Coverage Code	D - Special coverage instructions apply
HCPCS Action Code	N - No maintenance for this code
HCPCS Action Effective Date	July 01, 2022
HCPCS Code Added Date	April 01, 2022
HCPCS Pricing Indicator Code	53 - Statute
HCPCS Multiple Pricing Indicator Code	A - Not applicable as HCPCS priced under one methodology
HCPCS Coverage Issues Manual Reference Section Number
HCPCS Type Of Service Code	9 - Other medical items or services
HCPCS Anesthesia Base Unit Quantity	0